[go: up one dir, main page]

AR003406A1 - Derivados de imidazol, procedimiento para su preparacion y preparaciones farmaceuticas que los contienen. - Google Patents

Derivados de imidazol, procedimiento para su preparacion y preparaciones farmaceuticas que los contienen.

Info

Publication number
AR003406A1
AR003406A1 ARP950100495A AR10049595A AR003406A1 AR 003406 A1 AR003406 A1 AR 003406A1 AR P950100495 A ARP950100495 A AR P950100495A AR 10049595 A AR10049595 A AR 10049595A AR 003406 A1 AR003406 A1 AR 003406A1
Authority
AR
Argentina
Prior art keywords
contain
preparation
pharmaceutical preparations
imidazole
derivatives
Prior art date
Application number
ARP950100495A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR003406A1 publication Critical patent/AR003406A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Los derivados de imidazol de la fórmula general (I), en donde R1-R8 cada uno independientemente significan hidrógeno, alquilo inferior, alquilo inferiorsubstituido, alquenilo inferior, alcoxi inferior, alcoxi inferior substituido,alcoxicarbonilo inferior,halógeno, hidroxi, amino, mono-o di-(alquilo inferior)amino o nitro y sales farmacéuticamente aceptables de los mismos son inhibidores de proteína-quinasa y pueden ser usados como medicamentos, porejemplo para elcontrol de los t rastornos hiperproliferativos tales como arterioesclerosis, psoriasis y tumores así como también de alopecía. Lainvención comprende al procedimiento para su preparación y preparaciones farmacéuticas que los contienen.
ARP950100495A 1994-12-13 1995-12-11 Derivados de imidazol, procedimiento para su preparacion y preparaciones farmaceuticas que los contienen. AR003406A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH376894 1994-12-13

Publications (1)

Publication Number Publication Date
AR003406A1 true AR003406A1 (es) 1998-08-05

Family

ID=4263074

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP950100495A AR003406A1 (es) 1994-12-13 1995-12-11 Derivados de imidazol, procedimiento para su preparacion y preparaciones farmaceuticas que los contienen.

Country Status (16)

Country Link
US (1) US5959113A (es)
EP (1) EP0797575B1 (es)
JP (1) JPH10510281A (es)
CN (1) CN1145623C (es)
AR (1) AR003406A1 (es)
AT (1) ATE252094T1 (es)
AU (1) AU4301096A (es)
BR (1) BR9509998A (es)
CA (1) CA2207404C (es)
DE (1) DE69531956T2 (es)
DK (1) DK0797575T3 (es)
ES (1) ES2208698T3 (es)
FI (1) FI972492A0 (es)
PT (1) PT797575E (es)
TR (1) TR199501561A2 (es)
WO (1) WO1996018626A1 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083949A (en) * 1995-10-06 2000-07-04 Merck & Co., Inc. Substituted imidazoles having anti-cancer and cytokine inhibitory activity
US5880139A (en) * 1996-11-20 1999-03-09 Merck & Co., Inc. Triaryl substituted imidazoles as glucagon antagonists
CA2271893A1 (en) * 1996-11-20 1998-05-28 Linda L. Chang Triaryl substituted imidazoles as glucagon antagonists
WO1998021957A1 (en) * 1996-11-20 1998-05-28 Merck & Co., Inc. Triaryl substituted imidazoles, compositions containing such compounds and methods of use
US6022884A (en) 1997-11-07 2000-02-08 Amgen Inc. Substituted pyridine compounds and methods of use
AU4506399A (en) * 1998-06-05 1999-12-30 Novartis Ag Aryl pyridinyl thiazoles
WO2000001688A1 (en) * 1998-07-02 2000-01-13 Sankyo Company, Limited Five-membered heteroaryl compounds
JP3850596B2 (ja) 1999-02-25 2006-11-29 本州化学工業株式会社 新規な部分保護トリスフェノール類とその製造方法
WO2003024447A1 (en) * 2001-09-20 2003-03-27 Smithkline Beecham Corporation Inhibitors of glycogen synthase kinase-3
AR039241A1 (es) 2002-04-04 2005-02-16 Biogen Inc Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos
US6790852B2 (en) * 2002-04-18 2004-09-14 Hoffmann-La Roche Inc. 2-(2,6-dichlorophenyl)-diarylimidazoles
CN101870691A (zh) 2002-08-19 2010-10-27 劳洛斯治疗公司 2,4,5-三取代的咪唑及其作为抗菌剂的用途
US7144889B2 (en) 2003-10-16 2006-12-05 Hoffman-La Roche Inc. Triarylimidazoles
CN100436450C (zh) * 2003-10-16 2008-11-26 霍夫曼-拉罗奇有限公司 三芳基咪唑
US7169781B2 (en) * 2003-10-17 2007-01-30 Hoffmann-La Roche Inc. Imidazole derivatives and their use as pharmaceutical agents
JP5095216B2 (ja) 2003-11-14 2012-12-12 ローラス セラピューティクス インコーポレーテッド アリールイミダゾールおよびその抗癌剤としての使用
KR100905678B1 (ko) * 2005-02-18 2009-07-03 도쿠리쓰교세이호징 가가쿠 기주쓰 신코 기코 광학 활성 에폭시 화합물의 제조 방법, 및 상기 방법에사용하기 위한 착체 및 그의 제조 방법
ES2473597T3 (es) 2005-05-25 2014-07-07 Lorus Therapeutics Inc. Derivados de 2-indolil imidazo[4,5-d]fenantrolina y su uso en el tratamiento del cáncer
JP5283872B2 (ja) * 2006-09-27 2013-09-04 シスメックス株式会社 腫瘍細胞に対する阻害剤の増殖抑制効果を評価する方法、及び腫瘍細胞の増殖を阻害する化合物をスクリーニングする方法
JP2010504974A (ja) * 2006-09-28 2010-02-18 フォリカ，インコーポレーテッド 新しい毛嚢を生成させ毛髪を成長させる方法、キット、及び組成物
CA2903866A1 (en) 2013-03-20 2014-09-25 Aptose Biosciences Inc. 2-substituted imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer
KR20160058960A (ko) 2013-10-04 2016-05-25 압토스 바이오사이언시스 인코포레이티드 암을 치료하기 위한 조성물과 방법
BR112016017993A2 (pt) 2014-02-03 2017-08-08 Quadriga Biosciences Inc Gama-aminoácidos beta-substituídos e análogos como agentes quimioterapêuticos
DK3102195T3 (da) 2014-02-03 2021-12-20 Quadriga Biosciences Inc Beta-substituerede beta-aminosyrer og analoger som kemoterapeutiske midler
ES2926931T3 (es) * 2014-02-07 2022-10-31 Agency Science Tech & Res Inhibidores de caseína quinasa 1 basados en azoles 2,4,5-tri-sustituidos como inductores de la cardiomiogénesis
EP3331851A1 (en) 2015-08-03 2018-06-13 Quadriga Biosciences, Inc. Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof
CN109212045A (zh) * 2017-07-04 2019-01-15 万全万特制药（厦门）有限公司 草酸艾司西酞普兰残留溶剂和杂质的分离测定方法
AU2018360477A1 (en) 2017-10-30 2020-06-04 Aptose Biosciences Inc. Aryl imidazoles for the treatment of cancer
CN114262298B (zh) * 2021-12-03 2023-09-26 郑州轻工业大学 2-溴-4-n,n-二甲氨基咪唑及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3707475A (en) * 1970-11-16 1972-12-26 Pfizer Antiinflammatory imidazoles
US3940486A (en) * 1971-05-10 1976-02-24 Ciba-Geigy Corporation Imidazole derivatives in the treatment of pain
CH561717A5 (es) * 1971-05-10 1975-05-15 Ciba Geigy Ag
MC2096A1 (fr) * 1989-02-23 1991-02-15 Hoffmann La Roche Pyrroles substitues
DE69322254T2 (de) * 1992-01-13 1999-04-29 Smithkline Beecham Corp., Philadelphia, Pa. 19101 Pyridyl-substituierte imidazole
MX9300141A (es) * 1992-01-13 1994-07-29 Smithkline Beecham Corp Compuestos de imidazol novedosos, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
EP0654024A1 (en) * 1992-08-06 1995-05-24 Warner-Lambert Company 2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor properties
ZA945363B (en) * 1993-07-21 1995-03-14 Smithkline Beecham Corp Novel compounds
CN1048731C (zh) * 1993-09-17 2000-01-26 史密丝克莱恩比彻姆公司 编码细胞因子抑制性抗炎药物结合蛋白质的多核苷酸

Also Published As

Publication number Publication date
EP0797575B1 (en) 2003-10-15
ES2208698T3 (es) 2004-06-16
EP0797575A1 (en) 1997-10-01
US5959113A (en) 1999-09-28
MX9704263A (es) 1997-09-30
WO1996018626A1 (en) 1996-06-20
ATE252094T1 (de) 2003-11-15
DE69531956T2 (de) 2004-07-29
CA2207404A1 (en) 1996-06-20
FI972492L (fi) 1997-06-12
FI972492A7 (fi) 1997-06-12
FI972492A0 (fi) 1997-06-12
TR199501561A2 (tr) 1996-07-21
CN1175252A (zh) 1998-03-04
AU4301096A (en) 1996-07-03
PT797575E (pt) 2004-02-27
JPH10510281A (ja) 1998-10-06
DE69531956D1 (de) 2003-11-20
CN1145623C (zh) 2004-04-14
BR9509998A (pt) 1997-12-30
CA2207404C (en) 2004-06-29
DK0797575T3 (da) 2004-02-16

Similar Documents

Publication Publication Date Title
AR003406A1 (es) Derivados de imidazol, procedimiento para su preparacion y preparaciones farmaceuticas que los contienen.
CY1107147T1 (el) Παραγωγα ινδαζολης και φαρμακευτικες συνθεσεις για αναστολη των κινασων πρωτεϊνης και μεθοδοι για τη χρηση τους
ECSP22012347A (es) Derivados de 2-morfolinopiridina sustituidos como inhibidores de la cinasa atr
AR007857A1 (es) Compuestos heterociclicos fusionados como inhibidores de proteina tirosina quinasa, sus metodos de preparacion, intermediarios uso en medicina ycomposiciones farmaceuticas que los contienen.
NO20005535L (no) Pyrazol-derivater som P-38 MAP kinase-inhibitorer
ATE267200T1 (de) Bicyclische kinase inhibitoren
TR200001174T2 (tr) Protein tirozin kinaz ve protein serin/treonin kinaz inhibitörleri olarak ikameli oksindol türevleri
BR0014225A (pt) Derivados de pirazol
ES2148178T3 (es) Uso de derivados de sulfamato como inhibidores de esteroide-sulfatasa.
NO20010887L (no) Quinazolin derivater
ECSP056246A (es) DERIVADOS DE PIRROLO [3,4-c]PIRAZOL ACTIVOS COMO INHIBIDORES DE QUINASA
EA200000488A1 (ru) Замена катехина на биоизостеру индазола в терапевтически активных соединениях
CR20120009A (es) 2-indolinonas sustituidas con pirrolos inhibidores de proteinquinasas (divisional exp. 6728)
TR199900048T2 (xx) Protein tirozin kinaz inhibit�rleri olarak bisiklik heteroaromatik bile�ikler
MY134848A (en) Pyrrolo[2,1-f] [1,2,4] triazine inhibitors of kinases
AR007856A1 (es) Compuestos heterociclicos fusionados como inhibidores de proteina tirosina, quinasa, sus metodos de prepraracion, intermediarios, uso en medicina ycomposiciones farmaceuticas que los contienen
AR008853A1 (es) Nuevos compuestos farmaceuticamente activos, su uso en la fabricacion de medicamentos, metodo de tratamiento, composicion farmaceutica, compuestosintermediarios y proceso para la fabricacion de dichos compuestos
UY27370A1 (es) Derivados de benzamida tiazol y composiciones farmacéuticas para inhibir la proliferación de células y métodos para su utilización
BR0014973A (pt) Heterociclos de nitrogênio bicìclico de alquilamino substituìdo como inibidores de proteìna quinase p38
ATE425142T1 (de) Inhibitoren von c-jun n-terminal kinasen (jnk)
BR0215360A (pt) Derivados de indolina úteis como inibidores de proteìna quinase
TR200103789T2 (tr) Tirozin kinaz inhibitörleri olarak ikameli 1,4-dihidroindeno[1,2-C]pirazoller.
ES2149985T3 (es) Derivados imidazolilalquilo de imidazo(1,5-a)indol-3-ona y su uso como agentes terapeuticos.
UY24313A1 (es) Procedimiento para preparar compuestos heterociclicos
ECSP951520A (es) Heterociclil- benzoilguanidinas, procedimiento para su preparacion y preparaciones farmaceuticas que las contienen